W
PBYI icon

WealthCollab’s Puma Biotechnology PBYI Stock Holding History

WealthCollab’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.71K Sell
950
-206
-18% -$1.51K ﹤0.01% 631
2026
Q1 		$7.39K Hold
1,156
– – ﹤0.01% 610
2025
Q4 		$6.88K Hold
1,156
– – ﹤0.01% 646
2025
Q3 		$6.14K Hold
1,156
– – ﹤0.01% 636
2025
Q2 		$3.97K Buy
1,156
+845
+272% +$2.7K ﹤0.01% 685
2025
Q1 		$921 Buy
+311
New +$973 ﹤0.01% 847

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WealthCollab's PBYI Position: Q2 2026 in Review

WealthCollab reduced its Puma Biotechnology (PBYI) stake by 18% in Q2 2026, selling an estimated $1.51K and leaving 950 shares worth $7.71K. The position accounts for ﹤0.01% of the portfolio, ranked #631.

WealthCollab first reported a position in PBYI in Q1 2025 and has held it in 6 quarters since. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • WealthCollab held 950 shares of Puma Biotechnology worth $7.71K as of Q2 2026.
  • WealthCollab sold 206 Puma Biotechnology shares in Q2 2026, an estimated $1.51K.
  • Puma Biotechnology made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #631 holding.
  • WealthCollab first reported a position in Puma Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.